Marex Group Limited

NasdaqGS:MRX 주식 리포트

시가총액: US$5.0b

Marex Group 과거 순이익 실적

과거 기준 점검 5/6

Marex Group은 연평균 35.3%의 비율로 수입이 증가해 온 반면, Capital Markets 산업은 수입이 7.2% 증가했습니다. 매출은 연평균 27.3%의 비율로 증가했습니다. Marex Group의 자기자본이익률은 20.9%이고 순이익률은 10.8%입니다.

핵심 정보

35.35%

순이익 성장률

38.24%

주당순이익(EPS) 성장률

Capital Markets 산업 성장률10.26%
매출 성장률27.33%
자기자본이익률20.92%
순이익률10.77%
최근 순이익 업데이트30 Jun 2026

최근 과거 실적 업데이트

Recent updates

내러티브 업데이트 Aug 20

MRX: Higher Profitability And Volatility-Driven Trading Volumes Will Support Upside

Marex Group's analyst fair value estimate has been revised from $75.00 to $100.00 as analysts factor in slightly higher assumed profit margins and a higher future P/E multiple, despite modestly softer projected revenue growth and a marginally higher discount rate. What’s in the News for Marex Group Marex Group reported Q2 2026 revenue of about US$696 million, up 39% year over year, with growth coming from all four business segments.
Seeking Alpha Aug 17

Recent Results From Marex Group Impress, But Some Risks Are Rising

Summary Marex Group delivered record H1 2026 revenue and profitability, with adjusted profit before tax of $318.6 million, driving an 18% stock surge on August 12. MRX's rapid acquisition strategy fueled significant YoY segment revenue growth, notably 134% in Market Making and 35% in Agency and Execution. Operational efficiency improved: adjusted profit margin rose 200 bps to 23%, and adjusted ROE reached 37.5%, nearly 700 bps higher YoY. Despite valuation concerns and increased risk from acquisitions and debt, I maintain a Buy rating on MRX given sustained earnings momentum. Read the full article on Seeking Alpha
내러티브 업데이트 Aug 06

MRX: Rich Earnings Multiple Will Confront Weaker Revenue And Index Exclusion Risk

Analysts have raised their price target for Marex Group from about $37.00 to roughly $44.00, reflecting updated assumptions on fair value, discount rate, revenue growth, profit margin and future P/E. What's in the News Marex Group completed the acquisition of European equity derivatives market maker Webb Traders, which focuses on single stock options for European and US mid and large cap equities.
내러티브 업데이트 Jul 23

MRX: Bermuda Move And Digital Collateral Shift Will Constrain Upside Potential

Analysts have raised their price target for Marex Group from $59.75 to $72.38, citing updated assumptions around revenue contraction, profit margin, and future P/E that together support a higher fair value estimate. What’s in the News for Marex Group Marex Group is allowing derivatives clients to post USDC stablecoin as initial margin collateral using Coinbase infrastructure, following a December 2025 CFTC no action letter that permits futures commission merchants to accept certain digital assets as margin.
내러티브 업데이트 Jul 08

MRX: Bermuda Redomiciliation Will Limit Future Upside From Current Levels

Analysts have nudged their price target for Marex Group higher from $57.13 to $59.75, citing updated assumptions that combine slightly softer revenue expectations with a small improvement in projected profit margins and a modestly higher future P/E multiple. What’s in the News for Marex Group Marex Group Limited completed its redomiciliation from England and Wales to Bermuda on July 1, 2026, following shareholder approval on May 21, 2026, and English High Court sanction on June 26, 2026.
내러티브 업데이트 Jun 22

MRX: Higher Fair Value And Market Volatility Tailwinds Will Support Upside

Analysts have raised their price target for Marex Group from $66.00 to $75.00, citing updated assumptions around revenue trends, a slightly higher discount rate, and modestly adjusted profit margin and P/E expectations. What’s in the News for Marex Group Night Watch Investment Management identified Marex Group plc as its largest holding, highlighting the futures clearing business as critical financial infrastructure with a strong and defensible market position, and pointing to earnings that have grown roughly 7x over the past five years, according to recent commentary from the firm.
내러티브 업데이트 Jun 05

MRX: Levmet Deal And Bermuda Move Will Support Measured Future Upside

Analysts have maintained their $57.13 price target for Marex Group, reflecting steady assumptions for its discount rate, an expected revenue decline of 7.25%, a profit margin of 20.12% and a future P/E of 11.49x. What's in the News Marex Group agreed to acquire Levmet, a Monaco based liquidity provider focused on base and ferrous metals, energy, and power.
내러티브 업데이트 May 22

MRX: Q1 2026 Guidance And Dividend Outlook Will Support Measured Upside

Analysts have raised their price target for Marex Group from $55.00 to $57.13, citing updated assumptions on revenue trends, profit margins and future P/E expectations. What's in the News Marex Group plc issued earnings guidance for the first quarter of 2026, with expected revenue in a range of $667 million to $697 million for the period ended March 31, 2026, compared with Q1 2025 revenue of $467 million (Key Developments).
내러티브 업데이트 May 07

MRX: Higher Margins And Q1 2026 Outlook Will Support Measured Upside

Analysts have lifted Marex Group's price target from $50.29 to $55.00 as they now factor in a higher profit margin of about 20.9% and a lower future P/E of roughly 9.7, despite softer revenue growth assumptions and a slightly higher discount rate. What's in the News Marex Group issued earnings guidance for the first quarter ended March 31, 2026, with expected revenues in a range of $667 million to $697 million, compared with Q1 2025 revenues of $467 million (Key Developments).
내러티브 업데이트 Apr 22

MRX: Higher Fair Value And Lower Future P/E Will Support Upside

Analysts have lifted their fair value estimate for Marex Group from $61.00 to $66.00, citing updated assumptions for modest positive revenue growth, a slightly higher profit margin, and a lower future P/E of 11.40 compared with the prior 13.35. What's in the News Marex Group issued earnings guidance for the quarter ending March 31, 2026, with expected revenues in a range of $667 million to $697 million, compared with Q1 2025 revenues of $467 million (Key Developments).
내러티브 업데이트 Apr 07

MRX: Rich Earnings Multiple Will Face Test From Softer Revenue Outlook

Analysts have inched their price targets for Marex Group higher by a few dollars into the mid $40s, reflecting updated views on revenue trends, margins, and a lower forward P/E assumption in recent TD Cowen, Piper Sandler, and Barclays research. Analyst Commentary Recent research reflects a mixed tone, with some optimism on Marex Group's revenue and margin outlook, alongside more cautious views on where the shares should trade relative to sector peers.
내러티브 업데이트 Mar 24

MRX: Volatility And Trading Volumes Will Test Fairly Priced Shares

Analysts have lifted their average price target on Marex Group by mid single digits. Recent moves include $7 and $5 increases, citing updated assumptions for revenue trends, profit margins, and a lower implied future P/E multiple despite a slightly higher discount rate.
내러티브 업데이트 Mar 09

MRX: Higher Trading Volumes And Supportive P/E Will Drive Future Upside

Analysts have lifted their average price target on Marex Group to $61, citing updated views on revenue trajectory, profit margins, and a modestly higher future P/E multiple informed by recent Street research revisions from TD Cowen, Piper Sandler, and Barclays. Analyst Commentary Bullish analysts are leaning into Marex Group's execution by lifting their individual price targets, which helps explain the higher Street average.
내러티브 업데이트 Feb 23

MRX: Rising Trading Volumes And Volatility Will Support Earnings Power

Narrative update on Marex Group Analysts have nudged their Marex Group price targets higher by $7 and $5 in recent updates, while one cut a target by $1 to $49. These changes reflect adjusted views on volumes, volatility, and earnings potential rather than a change to our $61 fair value estimate.
내러티브 업데이트 Feb 07

MRX: Higher Volatility And Volumes Will Support Earnings Power Going Forward

The analyst price target for Marex Group has increased from $56 to $61, with analysts citing updated views on revenue trends, profit margins, and future P/E assumptions reflected in recent research from TD Cowen, Piper Sandler, and Barclays. Analyst Commentary Recent research updates show bullish analysts lifting their fair value estimates for Marex Group, with the latest round of work incorporating refreshed views on revenue trends, margin resilience, and P/E assumptions.
내러티브 업데이트 Jan 23

MRX: US Expansion And Higher Trading Volumes Will Support Future Upside

Analysts have raised their price targets on Marex Group, reflecting a revised fair value estimate from $47.71 to $50.29 as they factor in updated expectations around volumes, revenue trends, margins, and future P/E assumptions following recent sector research. Analyst Commentary Recent research updates on Marex Group show a mix of optimism and caution as analysts refresh their models ahead of upcoming results and sector comparisons.
내러티브 업데이트 Jan 08

MRX: Rising Trading Activity Will Support Earnings Power Despite Slight Price Trim

Analysts have trimmed their price target on Marex Group to US$49 from US$50, citing refreshed views on sector volumes and volatility while keeping fair value and key valuation inputs broadly unchanged. Analyst Commentary Bullish analysts are treating the lower US$49 price target as a fine tuning rather than a reset, keeping their broader view on Marex Group intact while they refresh assumptions for sector activity.
내러티브 업데이트 Dec 23

MRX Will Benefit From Expanding US Structured Products And Margin Resilience

Analysts have trimmed their price target on Marex Group by 4 percent to $56.00, citing slightly higher discount rates and weaker revenue growth expectations, partly offset by improved profit margin forecasts and a more attractive forward earnings multiple. What's in the News Marex Group launched a US structured products business targeting RIAs, broker dealers, and private banks.
내러티브 업데이트 Dec 09

MRX: US Expansion Will Drive Future Upside Despite Pending Securities Lawsuits

Narrative Update on Marex Group Price Target Analysts have modestly reduced their averaged price target on Marex Group from approximately $49.00 to about $47.70. This reflects slightly weaker top line growth assumptions, partially offset by expectations for improved profit margins and a marginally lower future price to earnings multiple.
내러티브 업데이트 Nov 25

MRX: Diversified US Expansion Will Drive Recovery Despite Securities Lawsuit Risk

Analysts have raised their price target for Marex Group from $47.67 to $49.00, citing updated assumptions around profit margins and discount rates, which support a modestly higher valuation. What's in the News Marex Group has launched its structured products business in the United States, led by Scott Kerbel.
내러티브 업데이트 Nov 06

MRX: Revenue Outlook Will Support Rebound Despite Ongoing Class Action Lawsuits

Analysts have made a minor upward adjustment to the price target for Marex Group, now set at $47.67. This change is based on slight improvements in the revenue growth outlook and a stable discount rate.
내러티브 업데이트 Oct 23

Analysts Lower Marex Group Price Target Amid Accounting Allegations and Revised Profit Outlook

Analysts have slightly lowered their price target for Marex Group from $49.33 to $47.67. This change reflects recent updates to the company’s growth and profitability outlook.
내러티브 업데이트 Oct 08

Digitalization And M&A Will Unlock Global Market Potential

Analysts have lowered their price target for Marex Group from $50.89 to $49.33, citing slightly reduced profit margin forecasts and modestly improved revenue growth projections. What's in the News NINGI Research disclosed a short position in Marex Group, alleging the company used opaque off-balance-sheet entities, fictitious transactions, and misleading disclosures to obscure losses and inflate profits (Periodical).
User avatar
새로운 내러티브 Apr 27

Acquisitions Will Fuel APAC And Middle East Expansion

Strong market share gains and acquisition integration are driving revenue growth and expanding product offerings and geographic reach.

매출 및 비용 세부 내역

Marex Group가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.


순이익 및 매출 추이

NasdaqGS:MRX 매출, 비용 및 순이익 (USD Millions)
날짜매출순이익일반관리비연구개발비
30 Jun 263,4893761,4850
31 Mar 263,2663341,3860
31 Dec 252,8702941,2500
30 Sep 252,6682661,1560
30 Jun 252,6082511,1050
31 Mar 252,5302341,0520
31 Dec 242,3572059900
30 Sep 242,1421899390
30 Jun 241,8831341,2830
31 Mar 241,8491401,0280
31 Dec 231,8821287990
30 Sep 231,0921407370
30 Jun 231,8181394510
31 Mar 231,5701154510
01 Jan 231,010924590
01 Jan 22825573710
31 Dec 20758442770
31 Dec 19549362120
31 Dec 183841000
31 Dec 173181800
31 Dec 163282000
31 Dec 153461800

양질의 수익: MRX는 고품질 수익을 보유하고 있습니다.

이익 마진 증가: MRX의 현재 순 이익률 (10.8%)은 지난해 (9.6%)보다 높습니다.


잉여현금흐름 대비 순이익 분석


과거 순이익 성장 분석

수익추이: MRX의 수익은 지난 5년 동안 연평균 35.3%로 크게 증가했습니다.

성장 가속화: 지난 1년간 MRX 의 수익 증가율(49.7%)은 연간 평균(35.3%)을 초과합니다.

수익 대 산업: MRX의 지난 1년 수익 증가율(49.7%)은 Capital Markets 업계의 34.4%를 상회했습니다.


자기자본이익률

높은 ROE: MRX의 자본 수익률(20.92%)은 높음이지만 높은 부채 수준으로 인해 왜곡되어 있습니다.


총자산이익률


투하자본수익률


우수한 과거 실적 기업을 찾아보세요

기업 분석 및 재무 데이터 상태

데이터최종 업데이트 (UTC 시간)
기업 분석2026/08/21 04:54
종가2026/08/20 00:00
수익2026/06/30
연간 수익2025/12/31

데이터 소스

당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.

패키지데이터기간미국 소스 예시 *
기업 재무제표10년
  • 손익계산서
  • 현금흐름표
  • 대차대조표
분석가 컨센서스 추정치+3년
  • 재무 예측
  • 분석가 목표주가
시장 가격30년
  • 주가
  • 배당, 분할 및 기타 조치
지분 구조10년
  • 주요 주주
  • 내부자 거래
경영진10년
  • 리더십 팀
  • 이사회
주요 개발10년
  • 회사 공시

* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.

별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.

분석 모델 및 스노우플레이크

이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드YouTube 튜토리얼도 제공하고 있습니다.

Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.

산업 및 섹터 지표

산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.

분석가 소스

Marex Group Limited는 11명의 분석가가 다루고 있습니다. 이 중 7명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.

분석가기관
Benjamin BudishBarclays
Christopher AllenCitigroup Inc
Alexander BlosteinGoldman Sachs